Hormone Receptor Positive Breast Carcinoma trials recruiting in Ohio

All Hormone Receptor Positive Breast Carcinoma trials nationally

Cities in Ohio

Recruiting trials in Ohio

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Centerville, Cleveland, Columbus, Dayton
• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
  NCT06120283 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
  NCT07341503 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus